Update to 'A Contemporary Systematic Review on Liver Transplantation for Unresectable Liver Metastasis of Colorectal Cancer'.
Publication/Presentation Date
2-1-2024
Abstract
Colorectal cancer is the second most common cause of cancer-related death worldwide, and half of patients present with colorectal liver metastasis (CRLM). Liver transplant (LT) has emerged as a treatment modality for otherwise unresectable CRLM. Since the publication of the Lebeck-Lee systematic review in 2022, additional evidence has come to light supporting LT for CRLM in highly selected patients. This includes reports of >10-year follow-up with over 80% survival rates in low-risk patients. As these updated reports have significantly changed our collective knowledge, this article is intended to serve as an update to the 2022 systematic review to include the most up-to-date evidence on the subject.
Volume
31
Issue
2
First Page
697
Last Page
700
ISSN
1534-4681
Published In/Presented At
Wehrle, C. J., Fujiki, M., Schlegel, A., Whitsett Linganna, M., Pita, A., Kim, J. K., Kwon, D. C. H., Miller, C., Hashimoto, K., Dueland, S., Sasaki, K., Sapisochin, G., Line, P. D., Hernandez-Alejandro, R., & Aucejo, F. (2024). Update to 'A Contemporary Systematic Review on Liver Transplantation for Unresectable Liver Metastasis of Colorectal Cancer'. Annals of surgical oncology, 31(2), 697–700. https://doi.org/10.1245/s10434-023-14611-z
Disciplines
Medicine and Health Sciences
PubMedID
37996635
Department(s)
Department of Medicine
Document Type
Article